Partial Thickness Rotator Cuff Tear Clinical Trial
Official title:
A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipose-derived regenerative cell (ADRC) injection arm (ADRC treatment arm) and the SOC corticosteroid injection arm (active control arm). All subjects will be randomly assigned to ADRC treatment or active control arms in a 2:1 ratio and will be followed up for 6 months. The goal of the RC-004 study is to enroll all patients that were enrolled and treated in RC-002 and follow for 3 years.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01123889 -
Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
|
N/A | |
| Terminated |
NCT03597490 -
Multimodal Physical Therapy With Exercise in Partial-thickness Rotator Cuff Tears
|
||
| Recruiting |
NCT06414005 -
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear
|
Phase 2/Phase 3 |